HALO · Halozyme Therapeutics, Inc. · Fails to Deliver
$100.27
-0.40 (-0.40%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$11.43B
Shares
114.01M
Volume · Nov 13
2.28M
Avg daily vol (3M)
2.24M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-09 | 929 | $109.84 | $102,041 |
| 2026-10-07 | 1,201 | $109.72 | $131,774 |
| 2026-10-06 | 1,303 | $108.31 | $141,128 |
| 2026-10-05 | 2,568 | $109.86 | $282,120 |
| 2026-10-02 | 1,500 | $106.94 | $160,410 |
| 2026-09-29 | 64 | $112.89 | $7,225 |
| 2026-09-23 | 1,364 | $115.13 | $157,037 |
| 2026-09-21 | 20,214 | $112.45 | $2,273,064 |
| 2026-09-17 | 122 | $108.44 | $13,230 |
| 2026-08-31 | 395 | $105.35 | $41,613 |
| 2026-08-28 | 7,839 | $106.92 | $838,146 |
| 2026-08-25 | 22,676 | $108.64 | $2,463,521 |
| 2026-08-18 | 3,853 | $103.00 | $396,859 |
| 2026-08-17 | 704 | $98.66 | $69,457 |
Showing 1–14 of 14 settlements
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
619 filings
569 filers
Visit website
Investor relations